A company gives Pure Monograph a named molecule or development program. We return what the evidence supports, what previous trials teach, what alternative is grounded, and what evidence is still missing.
Same engine under asset intelligence (Build Monograph), Trial Autopsy, and Trial Counterfactual.
The molecule or development program a CEO, CSO, or Head of R&D is deciding. Lab files you upload go to our FastAPI backend and a Railway volume — see Privacy.
Live retrieval across scientific and regulatory sources, structured into a report — every claim traceable to its source.
Structure, formulation, clinical, and regulatory intelligence — with a clear mark wherever the public evidence runs out.
In this field, a confident wrong answer wearing a real citation is worse than no answer. Pure Monograph marks where the evidence ends — it doesn't paper over it.
No seat ladder. No priced extras on this page.
Free: one named-molecule report. No upload.
Enterprise: team workspace. Ask us.
One complimentary named-molecule report. No upload. Enterprise is a team workspace.
Request a program review See the two public lines